Showing results (701-710 of 6,487) with videos related to
Sort By:
Pageof 649
Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
A genetic basis for the interrelation of coagulation factorsC Y Vossen, P W Callas, S J Hasstedt, et al.Journal of Thrombosis and Haemostasis : JTH|August 29, 2007
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient miceA Jögi, J Pass, G Høyer-Hansen, et al.Journal of Thrombosis and Haemostasis : JTH|September 22, 2007
Protease-activated receptor-induced Akt activation--regulation and possible functionJ C Reséndiz, M H Kroll, R LassilaJournal of Thrombosis and Haemostasis : JTH|September 22, 2007
Fibrinogen angers with a new deletion (gamma GVYYQ 346-350) causes hypofibrinogenemia with hepatic storageN Dib, F Quelin, C Ternisien, et al.Journal of Thrombosis and Haemostasis : JTH|September 22, 2007
Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH StudyK Lacut, C Larramendy-Gozalo, G Le Gal, et al.Journal of Thrombosis and Haemostasis : JTH|September 22, 2007
Citrate anticoagulation and the dynamics of thrombin generationK G Mann, M F Whelihan, S Butenas, et al.Journal of Thrombosis and Haemostasis : JTH|December 2, 2006
Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I)B L De Stavola, T W MeadeJournal of Thrombosis and Haemostasis : JTH|December 2, 2006
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relativesE De Candia, A Pecci, G Ciabattoni, et al.Journal of Thrombosis and Haemostasis : JTH|December 2, 2006
Risk of excessive bleeding associated with marginally low von Willebrand factor and mild platelet dysfunctionB R Gudmundsdottir, V J Marder, P T OnundarsonJournal of Thrombosis and Haemostasis : JTH|April 6, 2007
A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacementG Agnelli, S Haas, J S Ginsberg, et al.Pageof 649